Climb Bio, Inc. (CLYM)

Climb Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25.8	87.23	93.11	43.59	46.92	20.49
Short-Term Investments	61.1	63.69	13.69	79.98	89.56	-
Cash & Short-Term Investments	86.9	150.92	106.8	123.57	136.48	20.49
Cash Growth	-55.05%	41.31%	-13.57%	-9.46%	566.18%	-3.47%
Other Receivables	-	1.12	2.46	6.59	7.02	-
Receivables	-	1.12	2.46	6.59	7.02	-
Prepaid Expenses	4.06	0.72	0.85	3.88	4.4	1.5
Other Current Assets	-	2.11	0.15	0.36	0.35	0.01
Total Current Assets	90.96	154.87	110.26	134.39	148.25	22
Property, Plant & Equipment	0.88	0.49	0.2	0.47	-	-
Long-Term Investments	88.93	61.61	-	-	24.92	-
Other Long-Term Assets	1.53	0.22	0.02	0.13	0.07	2.63
Total Assets	182.3	217.19	110.47	134.99	173.24	24.63
Accounts Payable	0.48	0.71	0.07	0.75	1.4	1.29
Accrued Expenses	4.24	4.04	1.23	5.05	4.63	1.22
Current Portion of Leases	0.23	0.16	0.33	0.3	-	-
Other Current Liabilities	-	0.03	1.2	-	-	-
Total Current Liabilities	4.95	4.93	2.83	6.1	6.03	2.51
Long-Term Leases	0.35	0.38	0.02	0.18	-	-
Other Long-Term Liabilities	-	-	0.02	-	0.01	-
Total Liabilities	5.3	5.31	2.87	6.28	6.04	2.51
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	448.74	441.73	263.58	249.93	242.94	3.15
Retained Earnings	-272.21	-229.88	-155.98	-120.86	-75.62	-28.14
Comprehensive Income & Other	0.47	0.02	-0	-0.36	-0.12	-
Total Common Equity	177	211.88	107.6	128.72	167.2	-24.98
Shareholders' Equity	177	211.88	107.6	128.72	167.2	22.12
Total Liabilities & Equity	182.3	217.19	110.47	134.99	173.24	24.63
Total Debt	0.58	0.53	0.35	0.48	-	-
Net Cash (Debt)	175.25	212	106.45	123.09	161.4	20.49
Net Cash Growth	-19.56%	99.15%	-13.52%	-23.74%	687.81%	-3.47%
Net Cash Per Share	2.59	4.40	3.94	4.68	13.16	9.36
Filing Date Shares Outstanding	68.18	67.48	27.72	26.57	26.57	3.48
Total Common Shares Outstanding	68.18	67.26	27.7	26.57	26.24	3.42
Working Capital	86.02	149.94	107.42	128.3	142.22	19.49
Book Value Per Share	2.60	3.15	3.88	4.84	6.37	-7.31
Tangible Book Value	177	211.88	107.6	128.72	167.2	-24.98
Tangible Book Value Per Share	2.60	3.15	3.88	4.84	6.37	-7.31

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q